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New Insights into the Lactate
Shuttle: Role of MCT4 in the Modulation
of the Exercise Capacity
Sara Bisetto,1 Megan C. Wright,2 Romana A. Nowak,3 Angelo C. Lepore,4 Tejvir S. Khurana,5 Emanuele Loro,5,*
and Nancy J. Philp1,6,*
SUMMARY
Lactate produced by muscle during high-intensity activity is an important end product of glycolysis
that supports whole body metabolism. The lactate shuttle model suggested that lactate produced
by glycolytic muscle fibers is utilized by oxidative fibers. MCT4 is a proton coupled monocarboxylate
transporter preferentially expressed in glycolytic muscle fibers and facilitates the lactate efflux. Here
we investigated the exercise capacity of mice with disrupted lactate shuttle due to global deletion of
MCT4 (MCT4 / ) or muscle-specific deletion of the accessory protein Basigin (iMSBsg / ). Although
MCT4 / and iMSBsg / mice have normal muscle morphology and contractility, only MCT4 /
mice exhibit an exercise intolerant phenotype. In vivo measurements of compound muscle action potentials showed a decrement in the evoked response in the MCT4 / mice. This was accompanied by a
significant structural degeneration of the neuromuscular junctions (NMJs). We propose that disruption of the lactate shuttle impacts motor function and destabilizes the motor unit.

INTRODUCTION
A hallmark of high-intensity exercise is the increased production of lactate by muscles, which is coupled
with an increase in lactate in circulation. Lactate was once considered a waste product of anaerobic glycolysis and the cause of muscle fatigue and decreased force generation (Hill et al., 1924). In the late 1980s,
George Brooks (Brooks, 1986) proposed that lactate produced by fast-twitch muscle fibers through both
aerobic and anaerobic glycolysis (Connett et al., 1990) is shuttled to oxidative fibers and to other organs
via circulation, to fuel oxidative metabolism during exercise.
1Department

Lactate is transported across the plasma membrane by monocarboxylate transporters (MCTs), encoded by
the SLC16A gene family (Adijanto and Philp, 2012). MCT1 (SLC16A1) and MCT4 (SLC16A3) are H+-coupled
lactate transporters found in the sarcolemma of skeletal muscle (Bonen, 2001; Wilson et al., 1998). MCT1
has higher affinity for lactate (Poole and Halestrap, 1993) and is predominantly expressed in slow-twitch
muscle fibers, where it facilitates the influx of lactate. MCT4 has lower affinity but higher capacity for lactate
transport (Dimmer et al., 2000) and is expressed in fast twitch where it mediates lactate efflux. The direction
of the flux is primarily controlled by the gradient of lactate and protons (Juel, 1997). To be trafficked to the
plasma membrane, MCT1 and MCT4 need to assemble in the ER with an accessory protein called Basigin
(Bsg or CD147) (Kirk et al., 2000), a member of the immunoglobulin superfamily. In Bsg knockout mice,
MCTs are not trafficked to the plasma membrane but are targeted for degradation (Philp et al., 2003).
The model of the lactate shuttle as a mechanism to distribute high-energy metabolites between glycolytic
and oxidative cells has been applied beyond skeletal muscle and exercise. It has been suggested that
lactate is shuttled between astrocytes and neurons during neuronal stimulation (Pellerin et al., 1998). In
the brain, it is not yet clear if the direction of the lactate shuttle is from astrocytes to neurons or vice versa.
Multiple studies have tried to address the question, but the results are still inconclusive as discordant findings have been published (Dı́az-Garcı́a et al., 2017; Mangia et al., 2009).
In this study, we have examined the contribution of the lactate shuttle to exercise capacity of mice using a
global Slc16a3 knockout (MCT4 / ) and an inducible muscle specific Bsg knockout mouse (iMSBsg / )
models. We performed in vivo and ex vivo analyses of exercise capacity, neuromuscular function, and
morphometry in these mouse models. Surprisingly, our results revealed that disruption of lactate transport

of Pathology,
Anatomy and Cell Biology,
Thomas Jefferson University,
Philadelphia, PA 19107, USA

2Department

of Biology,
Arcadia University, Glenside,
PA 19038, USA

3Institute

for Genomic
Biology, University of Illinois,
Urbana, IL 61801, USA

4Department

of
Neuroscience, Thomas
Jefferson University,
Philadelphia, PA 19107, USA

5Department

of Physiology
and Pennsylvania Muscle
Institute, Perelman School of
Medicine, University of
Pennsylvania, Philadelphia,
PA 19104, USA

6Lead

Contact

*Correspondence:
eloro@pennmedicine.upenn.
edu (E.L.),
nancy.philp@jefferson.edu
(N.J.P.)
https://doi.org/10.1016/j.isci.
2019.11.041

iScience 22, 507–518, December 20, 2019 ª 2019 The Authors.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

507

B

30
20
10

MCT4 +/+
MCT4 -/-

0

200

10 20 30 40 50

EDL

TA

Sol

Quad Gastr Diaph Heart

+/+

150
100

MCT4

38

MCT1

38

β-Tub

49

50
0

0

C

250
Tissue weight (mg)

Body weight (g)

A 40

TA

EDL Sol. Gastr.

Age (weeks)

E

IIa/IIb/MCT1

MCT4+/+

D

MCT4

MCT1

WGA

MCT4

MCT1

MCT4-/-

WGA

Figure 1. MCT4 / Mice Have Normal Development
(A and B) (A) Weight gain over 40 weeks of age and (B) muscle weight at 3 months of age in MCT4+/+ and MCT4 / mice
(n = 15 per group). Values are mean and SEM.
(C) Western blot analysis of MCT4 and MCT1 expression in skeletal muscle and cardiac muscle. EDL, extensor digitorum
longus; TA, tibialis anterior; Sol, soleus; Quad, quadricep; Gastr, gastrocnemius; Diaph, diaphragm.
(D) Representative immunostaining of EDL frozen sections from MCT4 / and MCT4+/+ mice labeled with WGA (left, red)
and antibodies against MCT4 (middle, green) and MCT1 (right, green).
(E) Representative immunolabeling of EDL frozen sections with MCT1 (blue) and antibodies against type IIb (red) and IIa
(green) fibers. Scale bar, 50 mm.

decreased exercise performance without altering muscle structure/function and was accompanied by a
progressive structural and functional impairment of the neuronal component of the motor unit.

RESULTS
/

MCT4

Mice Develop Exercise Intolerance

/

MCT4
mice were purchased from Taconic Biosciences. The animals were born at normal Mendelian ratio, with no apparent defects at birth. There were no developmental delays noted in MCT4 / mice, as
confirmed by normal growth curves and comparable body (Figure 1A) and muscle (Figure 1B) weights between MCT4+/+ and MCT4 / mice.
MCT4 was previously shown to be expressed in fast-twitch muscle fibers (Bonen, 2001). In agreement with
this we found by western blot analysis of muscle lysates from MCT4+/+ mice that MCT4 was mainly expressed by glycolytic fast-twitch (EDL, TA, and quadriceps) and mixed (gastrocnemius) muscles. MCT4
was completely absent in muscles lysates prepared from MCT4 / mice (Figure 1C). MCT1, on the other
hand, was expressed in all muscle types, but at higher levels in oxidative slow-twitch muscles including soleus, diaphragm, and heart (Figure 1C). We performed immunofluorescent labeling on frozen sections of
the extensor digitorum longus (EDL) and found MCT4 was localized at the sarcolemma in all the fibers
of MCT4+/+ EDL muscles, where it co-localized with wheat germ agglutinin (WGA). No MCT4 labeling
was detected in frozen sections of EDLs from MCT4 / mice (Figure 1D). Because the MCTs are bidirectional and can function for influx or efflux of lactate, we examined whether MCT1 expression was increased
in the EDL for compensation. MCT1 immunofluorescence on EDLs cryosections showed that the transporter has a similar expression pattern from both MCT4+/+ and MCT4 / mice, where it was preferentially
expressed in oxidative fiber (smaller sized) (Figure 1D). Immunofluorescence labeling of EDL cross sections
labeled with antibodies detecting MCT1, type IIa MyHC (oxidative fibers), and type IIb MyHC (glycolytic
fibers) confirmed that the transporter is primarily expressed in IIa and IIx (identified as non-positive for
either IIa or IIb MyHC) fibers (Figure 1E).
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Figure 2. MCT4 / Are Exercise Intolerant
(A) Voluntary wheel running, cumulative number of revolutions over 60 h of MCT4 / and MCT4+/+ mice, at 3 and
12 months of age (n = 3 each group, One way-ANOVA test, ****p < 0.0001).
(B) Treadmill protocol for endurance test at 5 incline.
(C) Total distance reached in the endurance treadmill test by MCT4+/+ and MCT4 / mice at 3, 6, and 18 months of age
(n = 10 MCT4+/+ and 23 MCT4 / at 3 months, n = 10 MCT4+/+ and 15 MCT4 / at 6 months, n = 7 MCT4+/+ and 8
MCT4 / at 18 months, three independent groups. Student t test, *p < 0.05, **p < 0.001).
(D) Representative traces of cumulative number of shocks over time during treadmill test of MCT4 / and MCT4+/+ mice
at 6 months of age. All the data are rapresented as mean and SEM.
See also Figure S1.

To investigate whether alterations of lactate transport in MCT4 / mice could affect normal exercise performance, we tested MCT4 / and MCT4+/+ mice with voluntary wheel running and forced endurance
treadmill. Voluntary wheel activity was comparable between the two groups at 3 months of age but was
reduced by 2.5-fold in 12-month-old MCT4 / mice (Figure 2A).
The endurance treadmill protocol was designed to gradually increase the running speed over time, up to
26 m/min, a speed at which oxygen consumption in C57BL/6 mice reaches approximately 80% of VO2max
(high-intensity exercise) (Desai and Bernstein, 2001) (Figure 2B). At high-intensity, most of the energy to
support muscle activity is derived from carbohydrates, resulting in the production and release of lactate
from muscle fibers and the consequent increase in blood lactate. Consistently, blood glucose decreased
by 30% after treadmill (Figure S2). Treadmill performance declined with age in both genotypes and,
consistent with the wheel running results, MCT4 / mice ran less compared with controls (Figure 2C).
MCT4 / mice could reach the maximum speed but, unlike MCT4+/+, could not endure the high-intensity
performance, as indicated by the quicker accumulation of electric shocks over time (Figure 2D). This suggests that, indeed, lack of MCT4 and disruption of muscle lactate efflux cause an age-dependent and exercise-intensity-dependent impairment of exercise capacity.

Lack of MCT4 Does Not Affect the Intrinsic Properties of the EDL Muscle
To determine if the exercise intolerance was due to structural alterations of MCT4 / muscle fibers, we performed a histological analysis of EDL cross sections, looking for signs of degeneration, fibrosis, or fiber type
switch. We focused on EDL muscles for a variety of reasons: first, EDL is highly engaged during locomotion
in rodents; second, it expresses high levels of MCT4 and its fiber type composition is primarily fast; and
finally, it can be easily and consistently dissected for functional studies.
H&E staining showed normal fiber morphology with no signs of immune infiltrates, fibrotic tissue, or central
nucleation (Figure 3A). Consistent with the normal muscle mass (Figure 1B), fiber size measured as minimum Feret diameter was comparable between genotypes both at 3 and 12 months of age (Figures 3B
and 3C).
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Figure 3. Skeletal Muscle Histology Is Not Affected by the Lack of MCT4
(A) Representative H&E staining of EDL cryosections from MCT4+/+ and MCT4 / mice; scale bar, 50 mm.
(B and C) Frequency histograms of fiber size of EDLs measured as minimum Feret diameter from MCT4+/+ and MCT4 / at (B) 3 and (C) 12 months (n = 5 each
group, counting all the fibers in the entire muscle section).
(D) Representative immunolabeling of MCT4+/+ and MCT4 / EDL sections with antibodies against type IIB and IIa fibers and laminin for sarcolemma.
(E and F) Percentage of IIb and IIa fiber types in EDLs from MCT4+/+ and MCT4 / at (E) 3 and (F) 12 months of age (n = 5 each group, two-way ANOVA test).
All the data are rapresented as mean and SEM.

Changes in muscle metabolism are often correlated with changes in the proportion of glycolytic and oxidative fibers. To address this possibility, we immunolabeled EDL frozen sections with antibodies against the
myosin heavy chain (MHC) isoforms (Figure 3D). The relative abundance of each fiber type was similar between genotypes at 3 and 12 months of age (Figures 3E and 3F).
To determine if the exercise intolerance in MCT4 / mice could be caused by defects in muscle contractility, we performed an ex vivo assessment of strength and fatigability in isolated EDL muscles using field
depolarization. This technique bypasses the neuronal and neuromuscular junction (NMJ) components and
focuses specifically on measuring the contractile and metabolic properties of the muscle. Isometric twitch
and tetanic forces, both absolute (Table S1) and after normalization by cross-sectional area (CSA) (Figures
4A and 4B), were not different between MCT4 / and MCT4+/+. Similar optimal length (L0), mass, and CSA
were consistent with the tissue weight measurements (Figure 1B) and the histomorphometric analyses (Figures 3A–3C). EDL muscles from MCT4+/+ and MCT4 / mice had similar fatigability profiles (Figure 4C), as
determined by administering repeating submaximal tetanic contractions every second for 8 min. The same
trend was found in younger (3 months old) and older (18 months old) mice (data not shown). This was
despite significant differences in the accumulation of intramuscular lactate, which was higher (50%) in
MCT4 / stimulated muscles compared with the unstimulated and MCT4+/+ conditions (Figure 4D). Therefore, intramuscular accumulation of lactate due to lack of MCT4 did not have an effect on muscle contractility. Because MCT4 is a proton-linked lactate transporter and contributes to the control of the intracellular
pH, we tested whether other pH modulators like carbonic anhydrases 2, 3, and 4 (Car2, Car3, Car4) or proton exchangers such as Mct1 and Na+/H+ exchanger (Nhe1) were overexpressed in the MCT4 / muscle as
a compensatory response. qPCR analysis of TA muscles from 6-month-old mice showed no difference in the
expression of these genes (Figure 4E). Together, these data suggest that lactate accumulation in muscle
does not alter muscle contractility or fatigability and therefore is not the main cause of the reduced exercise
capacity of MCT4 / mice.

iMSBsg

/

Mice Have Normal Exercise Capacity

To strengthen our finding and further investigate whether deletion of MCT4 in muscle could have any effect
on exercise capacity, we generated mice with a skeletal muscle-specific deletion of Basigin (BSG). BSG is
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Figure 4. Lack of MCT4 Does Not Impair the Contractile Properties of the Skeletal Muscles
(A and B) (A) EDL twitch and (B) tetanic forces generated ex vivo (n = 4 each group).
(C) EDL fatigue traces (n = 4 each group).
(D) Intramuscular lactate in unstimulated and stimulated gastrocnemius muscles (n = 4 each group, two-way ANOVA test,
interaction: p < 0.01, stimulation: ***p < 0.001, genotype: *p < 0.05).
(E) qPCR analysis of genes involved in pH control in TA muscles of 6-month-old MCT4+/+ and MCT4 / mice
(n = 3 MCT4+/+ and 5 MCT4 / ). All the data are rapresented as mean and SEM.

the accessory protein required for maturation and trafficking of both MCT1 and MCT4 to the sarcolemma.
When Bsg is knocked out, MCT1 and MCT4 fail to traffic to the plasma membrane and are targeted for
degradation. Specific deletion of Bsg in skeletal muscle was achieved by crossing BsgFlox/Flox mice with
the tamoxifen-inducible skeletal muscle-specific cre recombinase mice, Acta1-cre mice. The cre recombinases was induced when the mice reached 12 weeks of age to avoid possible developmental effects of the
lack of BSG. Western blot analysis confirmed that Bsg was ablated from skeletal muscle of iMSBsg / mice
and that the cre-recombinase driven by Acta1 was not active in the cardiac muscle (Figure 5A). BSG, MCT1,
and MCT4 were undetectable in lysates prepared from skeletal but not cardiac muscle.
Since tamoxifen can acutely affect cardiac muscle contractility (Asp et al., 2013), after the induction of the
cre recombinase, we waited 3 weeks for the tamoxifen to be completely cleared from the system before
testing the animals for exercise capacity. Using the forced treadmill test, we found that there was no significant difference in the total distance run by the iMSBsg / mice compared with controls (Figure 5B).
We then tested whether the complete disruption of the lactate shuttle had an effect on the contractile
properties of the muscles by performing ex vivo measurements of force and fatigability in isolated EDLs.
As for the MCT4 / muscles, we did not detect any difference in maximal isometric force (Figures 5C
and 5D) and fatigability (Figure 5E) between iMSBsg / and control mice. Since the MCT4 / presented
a decrease in exercise capacity already at 3 months and we did not observe any difference between controls and iMBsg / , we did not investigate the performance of these animals at older ages. Overall, the
studies on iMSBsg / mice confirmed that the absence of MCT1 and MCT4 in the sarcolemma of skeletal
muscle does not affect exercise capacity and muscle ex vivo contractile properties.

Loss of MCT4 Leads to Degeneration of the NMJ and Decreased Compound Muscle Action
Potential Amplitude
In many neuropathies (Hill, 2003), e.g., Charcot-Marie-Tooth disease (CMT) and Amyotrophic Lateral Sclerosis (ALS), a progressive decline in muscle strength and exercise capacity is caused by pathologies of the
motoneuron, nerves, and/or the NMJ rather than a primary defect in the muscle. We therefore investigated
whether ablation of MCT4 could impact the structure and function of the motor unit components upstream
of muscle.
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Figure 5. iMSBsg / Mice Do Not Show Exercise Intolerance
(A) Representative western blot analysis of BSG, MCT1, and MCT4 in skeletal muscles and cardiac muscle of iMSBsg /
and iMSBsg+/+ mice after tamoxifen or vehicle treatment.
(B) Total distance reached during the treadmill test by iMSBsg / and iMSBsg+/+ at 6 months of age (n = 5 each group).
Ex vivo EDL (C) twitch force, (D) tetanic force, and (E) fatigue traces (n = 3 each group). All the data are rapresented as
mean and SEM.
See also Figure S2

It was previously reported that MCT4 is expressed in astrocytes in the Central Nervous System (CNS),
particularly in the cortex and hippocampus of both rats and mice. qPCR analysis of Mct4 (Slc16a3)
mRNA in spinal cord samples demonstrated the presence of the transcript, although the levels were 100
times lower than in skeletal muscle (Figure 6A). To determine the cellular distribution of MCT4-expressing
cells in the spinal cord, we performed fluorescence in situ hybridization (FISH) on frozen sections from the
lumbar spinal cord of MCT4+/+ mice and co-labeled with nuclear staining and GFAP (Glial fibrillary acidic
protein), a marker for glial cells. The in situ hybridization showed widespread expression of Mct4 in both the
gray and white matter (Figure 6B). Since we detected Mct4 expression in the spinal cord, we sought to test
whether the lack of MCT4 affected the motor unit, beginning with the motoneuron. We used cresyl violet
staining in lumbar spinal cord cryosections to detect the Nissl substance in neurons (Figure 6C). We did not
detect any difference in the spinal cord histomorphological features between genotypes, with normal
boundaries between white and gray matter. Motor neurons were identified as Nissl-positive cells with a
clearly visible nucleus and a soma larger than 100 mm and were counted in three separate sections of
the lumbar spinal cord. The number of motoneurons was not different between MCT4 / and MCT4+/+
(Figure 6D), suggesting that lack of MCT4 does not induce neuronal cell death.
We then performed a morphometric analysis of the sciatic nerve of 6-month-old MCT4+/+ and MCT4 / mice
(Figure 6E) to determine if the lack of MCT4 altered the number, size, and/or myelination of axons. Toluidine
blue staining of semithin sciatic nerve sections revealed no differences in the density of myelinated axons; however, we found a small but significant increase in axons diameters in MCT4 / samples, driven by the increased
occurrence of large axons (Figure 6F). The g-ratio (a measure of myelin thickness) was similar between genotypes.
The synapse between the motoneurons and the skeletal muscle is called neuromuscular junction (NMJ).
Alterations in the NMJ are associated with poor motor performance and exercise intolerance. We then
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Figure 6. Lack of MCT4 Does Not Affect the Morphology of Motoneurons
(A) mRNA expression of Mct4 in spinal cord and skeletal muscle. Values are normalized to Rplp0 housekeeping gene.
(B) In situ hybridization of Mct4 mRNA (red) in lumbar spinal cord cryosections (10 mm thickness). Sections were co-labeled
with nuclear DAPI staining (blue) and an antibody against GFAP (green). Scale bar, 200 mm; insert scale bar, 50 mm.
(C) Representative cresyl violet staining of lumbar spinal cord cryosections. Arrowheads in the enlarged insert indicate
motoneurons in the ventral horn. Scale bar, 400 mm; insert scale bar, 200 mm.
(D) Quantification of the number of motoneurons in lumbar spinal cord sections (25mm) of MCT4+/+ and MCT4 / mice
(n = 3 animals each group, three sections per animal evaluated).
(E) Examples of toluidine blue staining of semithin sections of sciatic nerves (0.5 mm thickness). Scale bar, 200 mm.
(F) Morphometric analysis of axon diameter and g-ratio in MCT4 / and MCT4+/+ sciatic nerves (n = 3 each group, entire
section was counted). *p < 0.05. All the data are rapresented as mean and SEM.

sought to understand if the lack of MCT4 affects the integrity of the NMJ. We assessed the morphology of
the NMJ in EDL and soleus muscles by performing whole-mount immunolabeling of the pre-synaptic axons
(SMI32 ab) and vesicles (SV2), as well as of the post-synaptic nicotinic acetylcholine receptors (alpha-bungarotoxin) (Figure 7A). Although we did not detect any significant difference in NMJ morphology in

iScience 22, 507–518, December 20, 2019
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Figure 7. NMJ Morphology and CMAPs Are Impaired in MCT4 / Mice
(A) Representative images of whole-mount immunohistochemistry of EDL muscles labeling motor axons (SMI32, green),
pre-synaptic nerve terminals (SV2, green) and post-synaptic endplate (rhodamine-conjugated a-bungarotoxin, red). I.,
intact; P.D., partially denervated; F.D., fully denervated; M.I., multiple innervated.
(B) Quantification of intact and disrupted NMJs in EDLs of 12-month-old MCT4 / and MCT4+/+ (n = 3 each group,
Chi-square, p < 0.0001).
(C) Representative CMAP trace showing the electromyographic signal recorded from gastrocnemius muscle (black trace)
upon stimulation of the sciatic nerve (green trace). Amplitude and RMS are indicated.
(D) CMAPs RMS (Root-Mean-Square) recorded at 20 Hz in 6-month-old MCT4 / and MCT4+/+ mice (n = 4 each group,
Student t test, *p < 0.05). All the data are rapresented as mean and SEM.
See also Figure S3

muscles from 6-month-old mice, the incidence of disrupted NMJs in EDL of 12-month-old MCT4 / mice
was significantly higher (p < 0.0001, Chi-square test), with signs of denervation and re-innervation (Figure 7A). In 12-month-old MCT4+/+ muscles, only a minimum number of NMJs showed signs of partial
denervation. Among the NMJs analyzed in MCT4 / mice, 15% were partially or total denervated and
8% had terminal sprouting (Figures 7A and 7B). The analysis of NMJs in the soleus muscles showed no difference between MCT4 / and MCT4+/+ mice (Figure S3A), suggesting that the effects of MCT4 ablation
are more evident in fast motor units. Analysis of the density of the acetylcholine receptors (AChRs) at the
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post-synaptic endplates showed a similar result, with an increase in the fragmentation of the NMJs of the
12-month-old MCT4 / mice compared with the MCT4+/+ (Figures S3B and S3C). No difference in the
integrity of the NMJs was detected in the 6-month-old mice.
To assess the functional activity of the motor unit, we performed in vivo compound muscle action potential
(CMAP) studies on 6-month-old MCT4+/+ and MCT4 / mice. We applied repeated sciatic nerve stimulations with increasing frequencies and recorded the evoked electromyographic (EMG) signal in the gastrocnemius muscle (Figure 7C). No difference was found in the amplitude decrement after 30 s of repetitive
stimulations (data not shown). CMAP amplitude, however, expressed as root mean squared (RMS), was
significantly lower in MCT4 / at all frequencies tested (Figure 7D). Interestingly, loss of NMJ integrity
and decreased CMAP amplitude have been described in patients with CMT (Elbracht et al., 2014) (Spaulding et al., 2016) (Cipriani et al., 2018). Together, these data suggest that ablation of MCT4 had a negative
effect on the structural and functional stability of the motor unit.

DISCUSSION
In the current study, we investigated whether disruption of the lactate shuttle had an effect on exercise capacity, by characterizing the phenotype of the MCT4 / mouse. The results of our study showed that mice
with a global knockout of MCT4 had defects in locomotion both when tested for spontaneous in-cage activity (wheel running) and forced treadmill exercise (Figure 2). The decrement in motor function was more
evident in the spontaneous activity after the mice reached the adult age, suggesting that the phenotype is
progressive, and exacerbated during forced endurance test (Figure 2C). By combining the results from the
MCT4 / mice with those obtained from the iMSBsg / , we can conclude that the deletion of lactate transporters from the skeletal muscles is not detrimental for the muscle itself. Instead, the exercise intolerance
observed is accompanied by a functional and structural impairment of the neuronal component of the motor unit. Although we cannot exclude that lack of MCT4 in the CNS affects behavior, the integration of
in vivo and ex vivo functional assessments with morphological analyses suggests that a motor neurons
and NMJs are mostly affected.
For decades, lactate was considered the cause of fatigue in exercising muscles based on experiments conducted in the 1920s on non-oxygenated frog muscles (Hill et al., 1924). The lactate shuttle hypothesis was
described over 30 years ago by Brooks (Brooks, 1986), who suggested that lactate is a substrate exchanged
between glycolytic and oxidative tissues/cells, allowing for the control of its cytosolic concentration. During
the past 20 years, researchers in the muscle and exercise physiology fields have worked to understand the
real effects of lactate and H+ during muscle activity (Allen et al., 2008; Azevedo et al., 2007). It has now been
established that lactate is not cause of fatigue (Posterino et al., 2001). The fate of the H+ ions, which are cotransported together with lactate during fatiguing muscle contraction (Kemp et al., 2006; Robergs et al.,
2004; Robergs, 2017), however, is still not clear. In our study we showed that in ex vivo electrically stimulated
MCT4 / muscles, despite a 2-fold accumulation of intramuscular lactate, there was no decrement in force
generation or fatigability (Figure 4), supporting the fact that increased lactate was not the cause of fatigue.
We also tested whether addition of exogenous L-lactate in the bath during the fatigue test could alter muscle performance, but no difference was detected (data not shown).
We used Bsg floxed mice to indirectly knock out both transporters in adult muscle, with the goal of testing
whether it would have a detrimental impact on exercise capacity. Mice ubiquitously lacking Bsg are reported to be sterile and with memory and learning deficits (Naruhashi et al., 1997), but their exercise capacity has not been investigated. To our surprise, there was no difference between controls and iMSBsg / in
terms of running capacity or ex vivo contractility. This result is in contrast to the lactate shuttle hypothesis
and more recent work, which suggest that lactate derived from skeletal muscle is a key metabolite utilized
by different tissues as energy substrate (Hui et al., 2017). We cannot exclude that the lack of both transporters and their binding partner, BSG, may have caused a metabolic reprogramming in the skeletal muscle to limit lactate production and utilization. Taken together, the results from the two mouse models show
that the systemic redistribution of muscle-derived lactate, operated by MCT1 and MCT4, can be bypassed
during exercise.
Since its conception, the lactate shuttle theory has been applied to other systems such as cancer and neuroenergetics. Pellerin and Magistretti (Pellerin et al., 1998) presented the astrocytes-neurons lactate shuttle
(ANLS) hypothesis where, in situations of high energy demand, astrocytes are a source of lactate and
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neurons are lactate consumers. Several studies have shown the expression of MCT4 in astrocytes in brain
cortex and hippocampus (Bergersen et al., 2001) (Rafiki et al., 2003). In this study, we investigated the presence of MCT4 in the spinal cord and the potential role of lactate in supporting motor neuron activity. The in
situ hybridization data (Figure 6B) showed that MCT4 is expressed by multiple cell types, but we did not
confirm the expression in any particular cell type. Based on information available from the Allen Brain Atlas,
as well as the topology of our in situ mRNA staining, we suggest that motoneurons are among the cells
expressing MCT4. This is surprisingly new since previous reports indicated that MCT4 is expressed only
in astrocytes. The neuronal MCT4 expression, in contrast with the ANLS hypothesis, is, however, supported
by several publications suggesting that neurons rely on glycolytic metabolism for energy production, when
stimulated (Gjedde and Marrett, 2001; Simpson et al., 2007) (Mangia et al., 2009) (Dı́az-Garcı́a et al., 2017).
Future investigations will need to address if MCT4 and lactate have roles in the viability of the motor neuron
and whether, as seen in several cancer studies (Marchiq et al., 2015), the blockade of lactate flux induces
senescence and impairs neuronal signaling.
By performing CMAP measurements on MCT4 / mice, we found a decrement in the amplitude of the EMG
signal upon direct stimulation (Figure 7). Lower CMAP amplitude is a hallmark of axonal neuropathies such
as CMT, multiple sclerosis (MS), and other pathologies of the NMJ. Despite the clear functional decline of
the motor capacity (Figure 2) and the lower CMAPs amplitude in young adult mice, we did not detect any
evident structural change in the sciatic nerve (Figure 6). This is consistent with the normal latency estimated
during our CMAP experiments in both young adult and old mice (Manganelli et al., 2016) (Cornett et al.,
2016).
Structural disruption of NMJs was evident in older mice (Figure 7), when the decline in spontaneous activity
is also more pronounced. The results suggested that MCT4 and lactate may have an effect on the long-term
integrity of the motor unit and NMJs. It is interesting to note that the degeneration of the NMJs was
observed only in EDL muscles, which express MCT4 at the sarcolemma, and not in soleus muscles, which
express mainly MCT1. Based on our results, we speculate that lactate released by the skeletal muscle may
be necessary for the stability of the NMJs either functioning as metabolic substrate or as signaling molecule. A variety of factors as myokines and neurotrophic factors are important for the structural and functional integrity of the NMJ (Lin et al., 2008, 2001). Indeed, exercise has been shown to induce remodeling
and adaptation of the NMJs (Deschenes et al., 2019), and lack or reduced muscle activity can have a detrimental effect on NMJ structure and function as seen during aging (Gonzalez-Freire, 2014).
It has been reported that MCT4 is expressed by Schwann cells of the peripheral nervous system (PNS) (Domènech-Estévez et al., 2015), where it might have a role in the maintenance of axon myelination. In our
model, we did not detect the expression of MCT4 mRNA or protein in the PNS and we also did not observe
any defect in axons myelination (Figure 6).
In conclusion, the results of our study show that the exercise intolerance observed in the MCT4 / mice is
not attributable to disruption of the lactate shuttle between fast-twitch and slow-twitch muscle fibers.
Rather, in the MCT4 / mice there is an instability of the motor unit and, in particular, a progressive degeneration of the NMJs. We propose that the lack of MCT4 from motoneurons decreases their activity possibly
by altering the coordinate action of the metabolic pathways responsible for ATP production. This may in
turn affect the release of neurotransmitters at the NMJs, hence the decreased amplitude of the CMAPs recorded. Therefore, the decreased overall activity of the MCT4 / mice is associated with instability and
premature degeneration of the NMJs. We suggest that the phenotype of MCT4 / mice is reminiscent
of neurodegenerative diseases such as Charcot-Marie-Tooth, Multiple Sclerosis, or ALS, and therefore it
would be interesting to evaluate the role of MCT4 in these pathologies.

Limitations
In the current study we found that the lack of MCT4 negatively affects the exercise capacity of the mice but it
had no impact on ex vivo muscle physiology. MCT4 / mice did exhibit a decrease in amplitude of the
CMAPs accompanied by structural changes at the levels of the NMJs. Although our data suggest that
the exercise intolerance is due to instability of the motor unit, our approach did not have sufficient resolution to determine whether the functional impairment of the NMJs is a cause or a consequence of exercise
intolerance. In addition, we could only detect MCT4 transcripts in the spinal cord since the immunostaining
to demonstrate the presence of the protein was not reliable because was giving a high non-specific signal
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also in the MCT4 / samples. We could not ascertain whether these effects resulted from lack of MCT4
expression in the motoneurons or astrocytes. In this study, owing to limited technology, we could not
show whether the lack of MCT4 had a direct effect on neurotransmitter release from the pre-synapses or
impaired activation of the motoneurons. Future studies using motoneurons and/or astrocytes MCT4 conditional knockout mice will help elucidate this important point.

METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.

SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.11.041.

ACKNOWLEDGMENTS
We thank the Bioimaging Shared Resource of the Sidney Kimmel Cancer Center (NCI 5 P30 CA-56036) and
the Penn Muscle Institute Muscle Physiology Assessment Core for muscle contraction study. This work was
primarily supported by the US National Institute of Health grants R01EY012042 to N.J.P. and R01NS079702
and R01NS110385 to A.C.L.

AUTHOR CONTRIBUTIONS
S.B, E.L., and N.J.P. designed and developed project and wrote the manuscript. S.B. and E.L. performed
experiments and analyzed data. M.C.W. performed NMJ analysis. R.A.N. provided Bsgflox/flox mice. A.C.L.
and T.S.K. contributed with reagents and discussion. All the authors read and reviewed the manuscript.

DECLARATION OF INTERESTS
The authors declare no competing interests.

Received: July 8, 2019
Revised: October 30, 2019
Accepted: November 22, 2019
Published: December 20, 2019
REFERENCES
Adijanto, J., and Philp, N.J. (2012). The SLC16A
family of monocarboxylate transporters (MCTs)–
physiology and function in cellular metabolism,
pH homeostasis, and fluid transport. Curr. Top.
Membr. 70, 275–311.
Allen, D.G., Lamb, G.D., and Westerblad, H.
(2008). Skeletal muscle fatigue: cellular
mechanisms. Physiol. Rev. 88, 287–332.
Asp, M.L., Martindale, J.J., and Metzger, J.M.
(2013). Direct, differential effects of tamoxifen,
4-hydroxytamoxifen, and raloxifene on cardiac
myocyte contractility and calcium handling. PLoS
One 8, e78768.
Azevedo, J.L., Tietz, E., Two-Feathers, T., Paull, J.,
and Chapman, K. (2007). Lactate, fructose and
glucose oxidation profiles in sports drinks and the
effect on exercise performance. PLoS One 2,
e927.
Bergersen, L., Waerhaug, O., Helm, J., Thomas,
M., Laake, P., Davies, A.J., Wilson, M.C.,
Halestrap, A.P., and Ottersen, O.P. (2001). A
novel postsynaptic density protein: the
monocarboxylate transporter MCT2 is colocalized with delta-glutamate receptors in
postsynaptic densities of parallel fiber-Purkinje
cell synapses. Exp. Brain Res. 136, 523–534.

Bonen, A. (2001). The expression of lactate
transporters (MCT1 and MCT4) in heart and
muscle. Eur. J. Appl. Physiol. 86, 6–11.
Brooks, G.A. (1986). The lactate shuttle during
exercise and recovery. Med. Sci. Sports Exerc. 18,
360–368.
Cipriani, S., Phan, V., Médard, J.-J., Horvath, R.,
Lochmüller, H., Chrast, R., Roos, A., and Spendiff,
S. (2018). Neuromuscular junction changes in a
mouse model of Charcot-Marie-Tooth disease
type 4C. Int. J. Mol. Sci. 19, 4072.
Connett, R.J., Honig, C.R., Gayeski, T.E., and
Brooks, G.A. (1990). Defining hypoxia: a systems
view of VO2, glycolysis, energetics, and
intracellular PO2. J. Appl. Physiol. 68, 833–842.
Cornett, K.M.D., Menezes, M.P., Bray, P., Halaki,
M., Shy, R.R., Yum, S.W., Estilow, T., Moroni, I.,
Foscan, M., Pagliano, E., et al. (2016). Phenotypic
variability of childhood Charcot-Marie-Tooth
disease. JAMA Neurol. 73, 645–651.
Desai, K.H., and Bernstein, D. (2001). Exercise and
oxygen consumption in the mouse. In
Cardiovascular Physiology in the Genetically
Engineered Mousee. Developments in
Cardiovascular Medicine, 238, B.D. Hoit and R.A.
Walsh, eds., Cardiovascular Physiology in the

Genetically Engineered Mousee. Developments
in Cardiovascular Medicine (Springer),
pp. 277–302.
Deschenes, M.R., Tufts, H.L., Noronha, A.L., and
Li, S. (2019). Both aging and exercise training alter
the rate of recovery of neuromuscular
performance of male soleus muscles.
Biogerontology 20, 213–223.
Dimmer, K.S., Friedrich, B., Lang, F., Deitmer,
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Figure S1, related to figure 2: Blood glucose measurement before and after
treadmill test: (A) Venus blood glucose measured in 6 months old MCT4+/+ and MCT4-/before and after treadmill test, ( n = 5 each group). Error bars = SEM.
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Figure S2, related to figure 5: Generation of the Bsg conditional mice. (A) Design
of targeting vector to produce floxed Bsg mouse with placement of LoxP sites to target
exon 1 of Bsg gene for deletion. (B) Southern blot confirmation of five ES clones (233,
234, 251, 253 and 272) as correctly targeted and used for injection.
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Fig S3, related to figure 7: Morphological analysis of NMJs in soleus muscles and
postsynaptic endplate: (A) Quantification of intact and disrupted NMJs in soleus
muscles of 12 months old MCT4-/- and MCT4+/+ (n = 3 each group). Quantification of the
density of Acetylcholine receptors (AChR) at the postsynaptic endplate from EDLs cross
sections from (B) 6 months old (n = 4 each group, 6 NMJs per animal) and (C)12 months
old (n = 3 each group, 3 NMJs per animal) MCT4+/+ and MCT4-/- mice. Error bars = SEM.

Table S1 related to Figure 4: Contractile and morphometric measurements of EDL muscles.
EDL contractility
Twitch force (mN)
Twitch force (N/cm2)
Tetanic force (mN)
Tetanic force (N/cm2)
Twitch - TTP (ms)
Twitch - RFD (mN/sec)
Fatigue AUC

MCT4+/+

N=4
94.68±13.90
5.36±0.62
345.08±53.87
19.42±2.10
20±0.42
12747.25±1909.27
956.90±83.52

MCT4-/-

N=5
118.22±4.71
6.04±0.13
447.76±7.18
22.95±0.57
20.10±0.27
14428.00±892.54
981.38±82.61

P
0.121
0.265
0.070
0.115
0.841
0.419
0.843

N=4
N=5
EDL morphometry
11.93±0.37
12.56±0.10
0.106
L0 (mm)
9.98±0.63
11.74±0.52
0.066
Mass (mg)
1.76±0.12
1.96±0.08
0.191
CSA (mm2)
Values are mean ± SEM. TTP, time to peak; RFD, rate of force development; CSA, cross sectional area; L0,
muscle length.

TRANSPARENT METHODS
Animals.
All animal procedures were performed in accordance with the Thomas Jefferson University Institutional
Animal Care and Use Committee. MCT4 (slc16a3) knock out mice, stock no. TF3223A, were obtained
from Taconic Farms. Mice were backcrossed for 10 generations to C57BL/6NTac to obtain a 99%
C57BL/6 background. Bsgflox/flox mice were obtained from Dr. Nowak at University of Illinois. The mice
were generated by inGenious Targeting Laboratory (www. Genetargeting.com). The construct was
designed to target exon 1 for conditional deletion as shown in the supplementary material (Fig. S1A).
Briefly, ten micrograms of the targeting vector were linearized by NotI and then transfected by
electroporation of BA1(C57Bl/6 x 129/SvEv) (Hybrid) embryonic stem cells. After selection with G418
antibiotic, surviving clones were expanded for PCR analysis and southern blotting to identify
recombinant ES clones. Sequencing was also performed on purified PCR DNA to confirm the presence
of the LoxP cassette using the SDL2 primer. Five positive clones were confirmed by southern blotting
(Fig. S1B) and used for blastocyst injection, implantation and generation of chimeras. Germline
transmission was confirmed in four of the clones. Bsgflox/flox were crossed with tamoxifen inducible Acta1cre/Esr1 mice (Jackson Lab, stock no 025750 HSA-MCM). Induction of the cre-recombinase was
obtained by daily injection of tamoxifen (2mg/kg), for 5 consecutive days. Bsgflox/flox:Cre+/- mice injected
with vehicle (15% ethanol in sunflower oil) were used as control. Mice were housed at 22ºC and under
12:12h light-dark cycle. Male mice were used in all the reported experiments except for the reported
wheels running test and NMJs morphology data.
Histology.
Tibialis anterioris (TA) muscle and extensor digitorum longus (EDL) muscles were frozen in Tissue-Tek
OCT compound (WVR, Atlanta GA) and stored at -80ºC. 10µm cryosections were cut and used for
subsequent histological and immunofluorescence stainings. For H&E staining, a standard procedure
was followed. For fiber typing analysis, sections were stained with monoclonal antibodies against
myosin heavy chains produced by Dr Schiaffino’s lab at University of Padova and distributed by the
Developmental Studies Hybridoma Bank (DHSB, University of Iowa). Ba-D5 (supernatant), specific for
MyHC-1 was used at 1:100 dilution, Bf-F3 (purified antibody), specific for MyHC-IIB was used at 1:100
and Sc-71 (supernatant), specific for MyHC-IIA, was used at 1:50. The secondary antibodies: donkey
anti-mouse IgG2b AlexaFluor647 to bind Ba-D5; donkey anti-mouse IgM AlexaFluor 555 to bind Bf-F3
and donkey anti-mouse IgG1 AlexaFluor 488 to bind Sc-71 (Life Technologies, New York) were diluted
1:500. Membranes were counterstained with anti-laminin antibody (L-9393, Sigma) or wheat germ
agglutinin (WGA) conjugated with AlexaFluor 488 or AlexaFluor 647 (Thermo Fisher). Images were
collected using the epifluorescence microscope Eclipse 800 (Nikon) and analysis of the distribution of
the different fiber types were performed with the ImageJ software. For the analysis of MCT1 and MCT4
distribution, anti-MCT1 and anti-MCT4 antibodies previously characterized by our laboratory (Philp et
al., 2003) were used. For spinal cord histological analysis, samples were collected and fixed overnight
in 4% paraformaldehyde. After cryopreservation in 30% sucrose solution the samples were frozen in
Tissue-tek OCT compound and stored at -80. For motoneurons analysis, 25um thick transversal
sections from the lumbar portion of the spinal cord were cut and stained with 0.5% cresyl violet acetate
solution and images were captured using cellSens Entry software and the Olympus DP22 camera
attached to an Olympus CX41 microscope (Olympus Scientific Solutions Americas). Motoneurons were
identified as larger polygonal cells, with diameter larger than 100μm in the ventral horn. For every
subject 3 different sections, 150 μm apart were evaluated.
Exercise tolerance test.
Exercise tolerance was assessed using a motorized Exer3-6 treadmill system with shock counter
(Columbus Instruments, Columbus OH). Mice were acclimated to the treadmill for 3 consecutive days
with a 10 minutes session at 0 incline (1- zero shock, 5m/min speed, 2- 1hz 0.5mA shock, 5m/min
speed for 5 min, 10m/min speed 5min, 3- 1hz 0.5mA shock, 10m/min speed). Between acclimation and
test the mice rested for 48h. The test was performed at 5º incline, it started at 10m/min and the speed
was increased by 2m/min every 3 minutes, until a maximum speed of 26m/min was reached. Maximum
speed, time on belt and distance run, as well as the number of the shocks received during the test,
were recorded. The mice were considered exhausted when they sat on the shock grid for 5 consecutive
seconds despite the shocks.

Voluntary wheel running test.
Mice were single housed in cages equipped with wheels (Columbus Instrument) for 7 days. Wheel
revolutions during the last 60 hours were acquired and analyzed.
RNA analysis.
RNA was extracted with TRIzol Reagent (Thermo Fisher) and cDNA synthesis was performed using
the RNA to cDNA EcoDry™ Premix kit (Clontech). SYBR green qPCR analysis was performed on the
QuantStudio 5 real time system (Thermo Fisher). Relative expression was calculated using Rplp0 as
housekeeping. The primers used were:
Car2: Fw CAGCGAGCAGATGTCTCATTTC, Rev TTCTTTAGCGGCTGAGCTGG,
Car3: Fw TTAAGACGAAGGGCAAGGAGG, Rev AGGAGCCGTGATAGGTCCAA,
Car4: Fw GAGCCAGCTATCCACGTTCC, Rev TTCCGGTCTGCTCTGCCTAT,
NEH1: Fw GCCTCATGAAGATAGGTTTCCA, Rev ACGTCTGATTGCAGGAAGGG,
MCT1: Fw TGTTAGTCGGAGCCTTCATT, Rev CACTGGTCGTTGCACTGAATA,
Rplp0: Fw: AGATTCGGGATATGCTGTTGGC, Rev TCGGGTCCTAGACCAGTGTTC.
Intramuscular lactate measurement.
After stimulation, muscles were rapidly frozen in liquid nitrogen. 30 to 50 mg of gastrocnemius muscle
were homogenized in ice cold 0.6M perchloric acid with a handheld homogenizer and then centrifuged
at 14000 rpm for 15 minutes. The supernatant pH was neutralized with 1.8M potassium carbonate. After
further centrifugation the supernatants were collected and used for lactate assay using a commercial
kit (Trinity Biotech).
Blood Glucose measurement.
Blood glucose was measured before and right after treadmill test from tail blood using a commercialy
available glucose meter (Precision Xtra Glucose Meter, Abbot)
Western Blot analysis.
Skeletal muscle tissue was homogenized in a buffer containing 50mM Tris, pH8, 150mM NaCl, 5mM
EDTA, 0.1% SDS, 1% Triton X-100 and 0.5% Deoxycholic acid. Samples were separated in a 4-12%
Bis-Tris precast Nupage gels (Thermo fisher) and blotted onto PVDF membranes. Membranes were
blocked in 5% no-fat milk in TBS-tween buffer and incubated overnight with primary antibodies. After
washing the membranes in TBS-tween buffer they were incubated in HRP conjugated secondary
antibodies for 1h at room temperature. We developed the blots using SuperSignal West Dura ECL
substrate (ThermoFisher Scientific) and imaged using FluorChem M ProteinSimple imager.
CMAP and ex vivo EDL contractility analysis.
During all ex vivo and in vivo procedures, the genotype of the mice was not disclosed to the operator.
For the analysis of Compound Muscle Action Potential (CMAP), mice were anesthetized with 1%
isoflurane. Depth of anesthesia was confirmed by toe pinch and by monitoring heart rate and SpO2 with
a pulse oximeter (PhysioSuite, Kent Scientific). The sciatic nerve was exposed, crushed distally to the
muscle to prevent retrograde propagation of the stimuli, and connected to a custom-made bipolar
stimulating electrode driven by a Grass S48 stimulator. Two recording silver EMG needle-electrodes
were applied at fixed distance (5 mm), one in the gastrocnemius and the other near the Achilles tendon.
The ground electrode was connected to the skin of the back of the mouse. The recording electrodes
were then connected to a Warner Instruments DP-311 differential amplifier, band-pass filtered (0.1-10k
Hz) and finally fed into a PowerLab/8Sp A/D converter (AD Instruments). One leg of each mouse was
electrically stimulated, while the other was left unstimulated and used to dissect the EDL muscle for ex
vivo contractility testing after completion of the CMAP protocol. Three trains of ten stimulating pulses
(5V, 0.1ms duration) were applied for each frequency tested (1, 3, 5, 10, 20, 40Hz), allowing 2 minutes
for recovery between each train. Data were acquired and analyzed with LabChart8 (AD Instruments),
calculating EMG amplitude and root mean square (RMS) of the signal.
Muscle physiological analysis was performed on isolated EDL muscles using an Aurora Mouse 1200A
System equipped with Dynamic Muscle Control v.5.415 software. EDL muscles were dissected and
analyzed in constantly oxygenated Ringer's solution (100mM NaCl, 4.7mM KCl, 3.4mM CaCl2, 1.2mM
KH2PO4, 1.mM MgSO4, 25mM HEPES, 5.5mM D-glucose) at 24°C. The twitch stimulation protocol
applied was a single stimulus with a duration of 0.2 ms. Muscle length was adjusted to obtain the
maximal twitch response and this length was measured and recorded as optimal length (L0). For
measuring tetanic maximal force generation, the stimulus was repeated at a frequency of 120Hz for
500ms. Five minutes were allowed between two tetanic contractions to ensure muscle recovery. For

induction of fatigue, 5 min after the last maximal tetanic contraction, muscles were stimulated every
second for 8 min using 40-Hz pulses lasting 330 ms. Muscle cross-sectional area (CSA) of EDL muscles
was calculated by dividing the muscle mass by the product of the muscle density coefficient (1.06
g/cm3), muscle L0, and the fiber length coefficient (0.45 for EDL). Specific force was determined by
normalizing maximum isometric tetanic force to CSA.
In situ hybridization.
RNAScope technology was used for in situ hybridization following manufacturer’s protocol. Briefly,
10um thick section were pretreated with hydrogen peroxide and protease. The slides were then
incubated with RNAScope probe (mmSlc16a3) for 2 h at 40ºC followed by the amplification steps
according to protocol. Signal was developed using the RNAscope 2.5 HD Manual Detection Kit Red.
The slides were then blocked in 5% BSA and immunostained with anti GFAP (Sigma) over night. The
next day donkey anti rabbit AlexaFluor 488 (Thermo Fisher) secondary antibody was applied for 1 hour
and after washing slides were mounted in ProLong Diamond antifade mounting media with DAPI
(Thermo Fisher). Images were captured on a Nikon Eclipse E800 with 4x/0.13 and 40x/0.75 DIC
objectives.
Sciatic nerve morphological analysis.
Sciatic nerves were dissected and fixed in 4% glutaraldehyde in 0.1M Millonig buffer for 2 hours, rinsed
in 0.54% glucose in Millonig buffer overnight and osmicated in 2% OsO4 for 45 minutes. After
dehydrations the samples were embedded in Durcupan resin. 500nm sections were cut with a glass
knife using a Leica UCT ultramicrotome, and then stained with 1% Toluidine blue and images were
captured with Olympus CX41 microscope (Olympus Scientific Solutions Americas). Morphometric
analysis of the myelinated axons was done with the Halo software, Axon module (IndicaLab,
Albuquerque NM, USA). Axons and fibers diameter were recorded, and g-ratio was calculated.
Neuromuscular junction staining.
EDLs and solei were dissected, cleaned from connective tissue and fixed in 4%PFA and processed for
immunohistochemistry as previously described (Wright et al., 2007). They were then incubated with
rhodamine-conjugated alpha-bungarotoxin (Thermo Fisher) to label acetylcholine receptors. After
permeabilization in methanol, samples were blocked in 2% BSA and then incubated overnight with
primaries antibodies, SMI-312R (Covance) and SV-2 (Hybridoma bank) for labeling motor axons and
terminal vesicles, respectively. After washing in PBS, samples were incubated for 1hour with with FITC
anti-mouse IgG secondary (Jackson ImmunoResearch). Samples were mounted with Vectashield
mounting media and coverslipped. Samples were then analyzed for total numbers of intact, completely
denervated, partially denervated and multiply innervated NMJs. Each junction was categorized as 1)
intact if there was complete overlap between presynaptic nerve terminal and postsynaptic AChRs, 2)
partially denervated with only partial occupation of postsynaptic AChRs by the overlying nerve terminal,
or 3) completely denervated, with no occupation of postsynaptic AChRs by the nerve terminal. To
ensure that a junction was completely denervated, and that the absence of the nerve terminal was not
an artifact of the staining procedure, junctions were only counted as completely denervated if there
were other nearby labeled junctions in the same viewing plane. Rapresentative images were captured
using a Nikon A1R confocal microscope, with a 40X/1.3 oil objective. For analysis of the post synaptic
endplate density, 25μm thick frozen cross sections of EDLs muscle were stained with rhodamineconjugated alpha-bungarotoxin. Z-stack images of en-face NMJs were collected using the Nikon A1R
confocal microscope and processed with ImageJ to obtain a maximum intensity projection from the Zstack. Using the Cell Profiler software the images were batch processed and total area occupied by the
staining and the perimeter were quantified. Dispersion index was calculated as ratio between the total
perimeter and total area.
Statistical analyses.
Data are represented as mean ± SEM. Data were processed and analyzed with GraphPad Prism 8
(GraphPad software). Before any statistical analysis was applied, data were assessed for normality
using the D’Agostino-Pearson’s test. Normally distributed data were compared using the student’s t
test, for non-normlly distributed data, the Mann-Whitney test was applied. Data in Fig.2A were analyzed
using a One-Way ANOVA test, followed by Tukey’s test for multiple comparisons. Data in Fig.3E-F and
4D were analyzed with a 2-way ANOVA test followed by Tukey’s test for multiple comparisons. For
analysis of NMJs in Fig.7B a Chi-square test was applied. P< 0.05 was considered statistically
significant.
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